HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Gert Van Assche Selected Research

Adalimumab (Humira)

2/2020The Ulcerative Colitis Response Index for Detection of Mucosal Healing in Patients Treated With Anti-tumour Necrosis Factor.
11/2019Outcome of biological therapies in chronic antibiotic-refractory pouchitis: A retrospective single-centre experience.
9/2019Subcutaneous Absorption Contributes to Observed Interindividual Variability in Adalimumab Serum Concentrations in Crohn's Disease: A Prospective Multicentre Study.
10/2018Influence of early adalimumab serum levels on immunogenicity and long-term outcome of anti-TNF naive Crohn's disease patients: the usefulness of rapid testing.
3/2017Sarcoidosis-Like Lesions: Another Paradoxical Reaction to Anti-TNF Therapy?
1/2017Systematic Review of Tumor Necrosis Factor Antagonists in Extraintestinal Manifestations in Inflammatory Bowel Disease.
3/2013Adalimumab dose escalation and dose de-escalation success rate and predictors in a large national cohort of Crohn's patients.
5/2012Adalimumab induces and maintains mucosal healing in patients with Crohn's disease: data from the EXTEND trial.
2/2012Switch to adalimumab in patients with Crohn's disease controlled by maintenance infliximab: prospective randomised SWITCH trial.
9/2011Outcome of pregnancy in women with inflammatory bowel disease treated with antitumor necrosis factor therapy.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Gert Van Assche Research Topics

Disease

97Crohn Disease (Crohn's Disease)
01/2021 - 08/2002
74Ulcerative Colitis
11/2020 - 10/2002
71Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
10/2020 - 02/2003
34Inflammation (Inflammations)
10/2020 - 08/2002
17Necrosis
03/2020 - 07/2006
17Colitis
01/2020 - 09/2002
14Infections
01/2020 - 01/2006
7Fibrosis (Cirrhosis)
01/2020 - 02/2003
7Fistula
05/2018 - 02/2003
5Pouchitis
11/2019 - 01/2008
5Neoplasms (Cancer)
01/2019 - 12/2008
5Pathologic Constriction (Stenosis)
05/2018 - 01/2004
5Rheumatoid Arthritis
08/2013 - 06/2005
3Body Weight (Weight, Body)
09/2019 - 03/2007
3Ulcer
12/2018 - 10/2004
3Ileitis
12/2013 - 09/2002
2Skin Neoplasms (Skin Cancer)
01/2019 - 08/2013
2Abscess
09/2018 - 02/2003
2Psoriasis (Pustulosis Palmaris et Plantaris)
05/2018 - 08/2013
2Anemia
01/2017 - 12/2007
2Tuberculosis (Tuberculoses)
06/2014 - 09/2011
2Nausea
12/2013 - 02/2003
2Iron Deficiencies
12/2013 - 12/2007
2Proctitis
07/2013 - 10/2002
2Opportunistic Infections (Opportunistic Infection)
05/2012 - 09/2008
2Acquired Immunodeficiency Syndrome (AIDS)
12/2008 - 12/2005
2Acute-Phase Reaction
12/2005 - 09/2004

Drug/Important Bio-Agent (IBA)

67Infliximab (Remicade)FDA Link
10/2020 - 08/2002
30Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
05/2018 - 08/2002
19Biological ProductsIBA
01/2020 - 02/2005
19SteroidsIBA
09/2018 - 02/2003
16Adalimumab (Humira)FDA Link
02/2020 - 07/2005
15Monoclonal AntibodiesIBA
01/2020 - 06/2005
14Pharmaceutical PreparationsIBA
03/2020 - 07/2003
13vedolizumabIBA
03/2020 - 02/2005
11Biomarkers (Surrogate Marker)IBA
02/2020 - 12/2005
11Adrenal Cortex Hormones (Corticosteroids)IBA
01/2019 - 05/2004
11AntibodiesIBA
10/2018 - 08/2002
10CytokinesIBA
11/2019 - 08/2002
9Azathioprine (Imuran)FDA LinkGeneric
03/2019 - 02/2003
9Phenobarbital (Luminal)FDA Link
02/2010 - 05/2004
8C-Reactive ProteinIBA
01/2020 - 09/2002
8Cyclosporine (Ciclosporin)FDA LinkGeneric
08/2013 - 02/2003
7Tumor Necrosis Factor InhibitorsIBA
01/2017 - 10/2010
6Interleukin-12 (IL 12)IBA
01/2020 - 07/2005
6Dextrans (Dextran)FDA Link
01/2020 - 01/2013
5Ustekinumab (CNTO 1275)FDA Link
01/2020 - 07/2017
5Immunologic Factors (Immunomodulators)IBA
01/2020 - 02/2009
5Leukocyte L1 Antigen Complex (Calgranulin)IBA
01/2020 - 09/2004
5Anti-Bacterial Agents (Antibiotics)IBA
11/2019 - 04/2005
5Immunosuppressive Agents (Immunosuppressants)IBA
07/2016 - 09/2008
5Natalizumab (Tysabri)FDA Link
09/2011 - 07/2005
4SodiumIBA
11/2019 - 01/2013
4IntegrinsIBA
01/2017 - 07/2005
4Immunoglobulin G (IgG)IBA
12/2007 - 06/2005
3Interleukin-23 (Interleukin 23)IBA
01/2020 - 07/2017
3Methotrexate (Mexate)FDA LinkGeneric
03/2019 - 09/2007
3golimumabFDA Link
12/2018 - 05/2016
3Messenger RNA (mRNA)IBA
01/2018 - 03/2007
3Prednisone (Sone)FDA LinkGeneric
10/2017 - 05/2015
3Matrix Metalloproteinases (MMPs)IBA
01/2017 - 02/2014
3AcidsIBA
01/2017 - 07/2004
3Matrix Metalloproteinase 9 (Gelatinase B)IBA
01/2017 - 07/2014
3IronIBA
12/2013 - 12/2007
3purineIBA
09/2012 - 07/2009
3Interferon-gamma (Interferon, gamma)IBA
03/2007 - 07/2005
2Sphingosine-1-Phosphate ReceptorsIBA
11/2020 - 05/2018
2Hydroxyproline (4 Hydroxyproline)IBA
01/2020 - 11/2019
2Drinking WaterIBA
01/2020 - 01/2018
2LactoferrinIBA
01/2020 - 09/2013
2Biosimilar PharmaceuticalsIBA
01/2020 - 01/2019
2sodium sulfate (sodium bisulfate)FDA LinkGeneric
01/2020 - 01/2018
2CT-P13IBA
01/2020 - 01/2019
2Interleukin-17 (Interleukin 17)IBA
11/2019 - 05/2018
2MicroRNAs (MicroRNA)IBA
07/2019 - 01/2014
22-mercaptopurineIBA
11/2018 - 08/2013
2Anti-Inflammatory Agents (Anti-Inflammatories)IBA
01/2017 - 12/2005
2Peptides (Polypeptides)IBA
01/2017 - 10/2007
2EnzymesIBA
05/2016 - 07/2014
2ImmunosorbentsIBA
05/2016 - 07/2014
2LipocalinsIBA
12/2015 - 07/2014
2Beclomethasone (Beclometasone)FDA Link
06/2015 - 05/2015
2Proteins (Proteins, Gene)FDA Link
02/2014 - 07/2006
2Mesalamine (Mesalazine)FDA LinkGeneric
06/2013 - 10/2002
2ChemokinesIBA
04/2011 - 07/2004
2visilizumabIBA
11/2010 - 11/2007
2Indomethacin (Indometacin)FDA LinkGeneric
08/2010 - 07/2005
2Immunoglobulins (Immunoglobulin)IBA
04/2009 - 05/2004
2Certolizumab PegolFDA Link
01/2009 - 12/2007
2EpitopesIBA
06/2008 - 10/2007
2PorinsIBA
06/2008 - 10/2007
2HaptensIBA
03/2007 - 07/2004
2OxazoloneIBA
03/2007 - 07/2004
2Interleukin-6 (Interleukin 6)IBA
12/2005 - 09/2004

Therapy/Procedure

90Therapeutics
01/2020 - 10/2002
14Colectomy
10/2017 - 09/2004
13Biological Therapy
01/2021 - 07/2006
5Restorative Proctocolectomy
11/2019 - 01/2008
2Intralesional Injections
05/2018 - 09/2016
2Transplantation
04/2016 - 11/2012